Anthony Letai, MD, PhD, FAACR, Lays Out NCI’s Priorities at the AACR Annual Meeting 2026
At the AACR Annual Meeting 2026, National Cancer Institute Director Anthony Letai offered insights into what NCI considers to...
At the AACR Annual Meeting 2026, National Cancer Institute Director Anthony Letai offered insights into what NCI considers to...
A recap of the first day of the AACR Annual Meeting 2026, including coverage of educational sessions and other...
By AACR Associate Member Council members, 2025-2026 Attending the AACR Annual Meeting is a defining moment for early‑career researchers...
A few AACR Runners for Research shared their thoughts as they prepare to pound some pavement and raise money...
AACR Associate Member Council members offer advice for how graduate students can make the most of AACR resources for...
A look behind the scenes into the planning of the AACR Annual Meeting, including the scientific program, conference logistics,...
Heather K. Beasley was among the researchers who visited Washington, D.C to push for sustained NIH funding during AACR...
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
The spring 2026 issue of Cancer Today included articles about using AI chatbots, cancer survivor—and “Survivor” winner—Ethan Zohn, and...
In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...
In November 2025, AACR on Campus events were held in Taiwan where local early-career researchers engaged with global leaders...